About Kalila Medical
Kalila Medical is a Healthcare company based in Campbell (United States) founded in 2010, and was acquired by Abbott in February 2016. Steerable introducer sheaths are developed for electrophysiology procedures. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include AtaCor Medical, Kestra Medical Technologies and CardioFocus; 3 of its 3 listed competitors have raised funding.
Company details
Kalila Medical was founded in 2010 in Campbell, United States, as a spin-out from Shifamed LLC, a Silicon Valley medical device incubator. Operations centered on the Vado Steerable Sheath, a torqueable introducer for atrial fibrillation and therapeutic device delivery in electrophysiology. Patent-protected truVector Technology was incorporated for tip deflection and torque control. Acquisition by Abbott Laboratories took place on February 2, 2016.
- Headquarters Campbell, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website kalilamedical.com
- Social LinkedIn
- Acquired by Abbott (Feb 2016)
Funding Insights of Kalila Medical
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Kalila Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2014 | Series A | β | Merieux Equity Partners | β |
2 investors in total: 2 institutional.
Investors in Kalila Medical
Kalila Medical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Abbott and Merieux Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pivate equity firm that focuses on investing in healthcare and nutrition companies | merieux-partners.com | Lyon, France | ||
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | abbott.com | Libertyville, United States |
Investor details for Kalila Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Kalila Medical
3 dated milestones of Kalila Medical across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Kalila Medical is founded.
- Funding First funding round.
- Exit Acquired by Abbott.
Competitors of Kalila Medical
Kalila Medical has 3 listed competitors in our database, 3 of them funded. They include AtaCor Medical, Kestra Medical Technologies and CardioFocus.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atacor.com | 2014 | San Clemente, United States | $136.8M | 15 | An implantable pacemaker system is developed for cardiac pacing therapy. | |
| kestramedical.com | 2014 | Kirkland, United States | $196M | 118 | Medical devices are developed to support cardiovascular patients at risk. | |
| cardiofocus.com | 1990 | Marlborough, United States | $260.86M | 105 | Endoscopic catheter for atrial fibrillation ablation is developed. |
Detailed competitors of Kalila Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Kalila Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kalila Medical
Complete news archive for Kalila Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalila Medical
Kalila Medical was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Kalila Medical is headquartered in Campbell, United States. It is registered at Campbell, California, United States.
Kalila Medical was founded in 2010 in Campbell, United States, as a spin-out from Shifamed LLC, a Silicon Valley medical device incubator. Operations centered on the Vado Steerable Sheath, a torqueable introducer for atrial fibrillation and therapeutic device delivery in electrophysiology. Patent-protected truVector Technology was incorporated for tip deflection and torque control. Acquisition by Abbott Laboratories took place on February 2, 2016.
Kalila Medical's top competitors include AtaCor Medical, CardioFocus and Kestra Medical Technologies.
Kalila Medical has 2 investors. Key investors include Abbott, and Merieux Equity Partners.
Yes. Kalila Medical was acquired by Abbott in February 2016.

